The agency, which is charged with preventing fraud, deception and unfair business practices, said Illumina’s acquisition of Grail would stifle competition and innovation in the U.S. market for life-saving cancer tests.

According to CMS, MA plans will see an average payment increase of 3.32% from 2023 to 2024, worth approximately $13.8 billion in increases for next year.

This latest recall is due to a heightened risk that the devices will stop working with no warning. There have been 42 customer complaints reported so far. 

The FDA has found a drug-resistant bacteria at an eye drop manufacturing facility linked to severe infections and even a few deaths.

The Affordable Care Act (ACA) was dealt a major blow after a federal judge ruled that employers don’t have to cover certain preventive services, including PReP, which prevents HIV.

The devices have been hit with multiple recalls in recent months. Those issues are now impacting sales outside of the United States as well.

Damar Hamlin, the Buffalo Bills safety who went into sudden cardiac arrest on the football field back in January, has also highlighted the importance of this new bipartisan legislation. 

Accurate information relative to personal risk is crucial for improving uptake of low-dose CT (LDCT) lung cancer screening, but new data indicate that many websites' content on the topic is out of date.